\Could someone give me the cost basis for AST when we received the shares from GERN.
PCYC shareholders had to wait 5 years for the final payout, I guess we only have 4 1/2 years of waiting left before the big day.
Not if its J&J holding the SP down in order to buy them out later at a lower price.
Its $260 per share and J&J still owns 50% of the drug Imbruvica. PCYC,like GERN, is a one drug company.
Unfortunately a real possibility----no morality in FDA or big pharma.
Their high road is only paved with cashola and greed!